Search hospitals > California > Palo Alto
Palo Alto Medical Foundation Health Care
Claim this profilePalo Alto, California 94301
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Cervical Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Breast cancer
182 reported clinical trials
13 medical researchers
Summary
Palo Alto Medical Foundation Health Care is a medical facility located in Palo Alto, California. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Cervical Adenocarcinoma, Lung Cancer, Breast cancer and other specialties. Palo Alto Medical Foundation Health Care is involved with conducting 182 clinical trials across 324 conditions. There are 13 research doctors associated with this hospital, such as Ari Baron, MD, Christopher Jones, Deepti Behl, and Kristie A. Bobolis.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Ari Baron, MDAlta Bates Summit Medical Center-Herrick Campus8 years of reported clinical research
Expert in Parotid Gland Cancer
Studies Lung Cancer
30 reported clinical trials
68 drugs studied
Christopher JonesSutter Medical Center Sacramento4 years of reported clinical research
Studies Parotid Gland Cancer
Studies Brain Tumor
26 reported clinical trials
69 drugs studied
Deepti BehlCalifornia Pacific Medical Center-Pacific Campus5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
50 drugs studied
Kristie A. BobolisSutter Medical Center Sacramento1 year of reported clinical research
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
24 drugs studied
Clinical Trials running at Palo Alto Medical Foundation Health Care
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast cancer
Parotid Gland Cancer
Ovarian Cancer
Kidney Cancer
Pancreatic Cancer
Skin Cancer
Squamous Cell Carcinoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Palo Alto Medical Foundation Health Care?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.